Correlation Between BiOasis Technologies and Algernon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BiOasis Technologies and Algernon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BiOasis Technologies and Algernon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between biOasis Technologies and Algernon Pharmaceuticals, you can compare the effects of market volatilities on BiOasis Technologies and Algernon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BiOasis Technologies with a short position of Algernon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BiOasis Technologies and Algernon Pharmaceuticals.
Diversification Opportunities for BiOasis Technologies and Algernon Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BiOasis and Algernon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding biOasis Technologies and Algernon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algernon Pharmaceuticals and BiOasis Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on biOasis Technologies are associated (or correlated) with Algernon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algernon Pharmaceuticals has no effect on the direction of BiOasis Technologies i.e., BiOasis Technologies and Algernon Pharmaceuticals go up and down completely randomly.
Pair Corralation between BiOasis Technologies and Algernon Pharmaceuticals
Assuming the 90 days horizon biOasis Technologies is expected to generate 3.27 times more return on investment than Algernon Pharmaceuticals. However, BiOasis Technologies is 3.27 times more volatile than Algernon Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Algernon Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 0.40 in biOasis Technologies on August 29, 2024 and sell it today you would lose (0.39) from holding biOasis Technologies or give up 97.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.21% |
| Values | Daily Returns |
biOasis Technologies vs. Algernon Pharmaceuticals
Performance |
| Timeline |
| biOasis Technologies |
| Algernon Pharmaceuticals |
BiOasis Technologies and Algernon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BiOasis Technologies and Algernon Pharmaceuticals
The main advantage of trading using opposite BiOasis Technologies and Algernon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BiOasis Technologies position performs unexpectedly, Algernon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algernon Pharmaceuticals will offset losses from the drop in Algernon Pharmaceuticals' long position.| BiOasis Technologies vs. Rezolute | BiOasis Technologies vs. Tempest Therapeutics | BiOasis Technologies vs. Forte Biosciences | BiOasis Technologies vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |